Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient populationCharles E. Mahan, Alex C. Spyropoulos, Maxine D. Fisher et al.|Thrombosis Research|2013Cited by 55
Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients After HospitalizationCharles E. Mahan, Winslow Klaskala, Alex C. Spyropoulos et al.|Clinical and Applied Thrombosis/Hemostasis|2013Cited by 15
Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticariaLiya Wang, Lisa A. Beck, Xuehua Ke et al.|Current Medical Research and Opinion|2017Cited by 14
Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With OmalizumabXuehua Ke, Jonathan Corren, Abhishek Kavati et al.|Clinical Therapeutics|2018Cited by 13
Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United StatesXuehua Ke, Lisa A. Beck, Debra Wertz et al.|Journal of Managed Care & Specialty Pharmacy|2018Cited by 13